Last reviewed · How we verify

NCT04239066

Penile Ischemia for Hypospadias Repair and The Patients and Surgeons Reported Outcomes

Completed NA Last updated 24 February 2021
What this trial tests

NA trial testing Tourniquet in Hypospadias in 110 participants. Completed in 1 December 2019.

Timeline
1 September 2017
Primary endpoint
1 December 2018
1 December 2019

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment110
Start date1 September 2017
Primary completion1 December 2018
Estimated completion1 December 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 6 Months to 36 Months, male only, with Hypospadias or Hypospadias, Coronal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although haemostasis aimed to maintain bloodless surgical field for better exposure for the surgeon, cosmetic impact, and decreased breakdown of repair, there is no trials regarding the impact of haemostasis techniques on surgeon satisfaction during surgery and patients reported outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tourniquet

Trials testing the same drug.

Other recruiting trials for Hypospadias

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing